chartexchange

VCNX
VACCINEX INC
stockOTC

EODNov 18, 2026
1.00USD0.000%(0.00)5,620
Loading…
Loading…
Healthcare
Biotechnology
HQ
Rochester, NY, USA
Previous Close
$1.00
Beta
0.95
52-Week High
$1.50 2026-05-04
52-Week Low
$0.31 2025-11-26
SMA 50
$0.97
SMA 200
$0.96
Avg. Vol 10D
1,530
Avg. Vol 30D
1,015
Avg. Vol 90D
2,256
Relative Vol
5.54
1.30M
Feb 20, 2024 · 1-for-14 (reverse)
Oct 1, 2026
VCNX Profile

located in rochester, ny, vaccinex is a privately held, clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies, therapeutic vaccines and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases. we conduct discovery research in-house and in collaboration with world-class academic institutions and biotechnology companies, and have an experienced in-house drug development management team to advance our pre-clinical and clinical stage biopharmaceutical development programs. our development team is led by seasoned industry veterans with both operational and executive level biopharmaceutical industry experience in therapeutic biologics research, manufacturing, quality assurance, quality control, toxicology, pharmacology, drug regulatory affairs, and clinical affairs. we are committed to innovation in the way we approach drug discovery and develop

VCNX Performance
PeriodPriceDateChangeBeta
6M1.032026-05-20-2.91%1.544
1Y0.692025-11-19+45.14%0.947
2Y3.262024-11-19-69.33%—
5Y350.702021-11-19-99.72%-0.160
VCNX Stock Summary

VACCINEX INC (OTC:VCNX) stock price today is $1.00, and today's volume is 5,620. VCNX is up 0.000% today. The 30 day average volume is 1,015. VCNX market cap is $2.68M with 2.68M shares outstanding.